Pharmaceutical Business review

Par Pharmaceutical signs distribution agreement with AstraZeneca

Par began shipping 0.25mg/2ml and 0.5mg/2ml to the trade. Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to eight years of age.